WallStreetZenWallStreetZen

NASDAQ: CKPT
Checkpoint Therapeutics Inc Stock Ownership - Who owns Checkpoint Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Checkpoint Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
William Garrett GrayChief Financial Officer2024-02-282,035$2.07
$4.21kSell
James F. Oliviero IiiCEO President and Director2024-02-285,894$2.06
$12.14kSell
William Garrett GrayChief Financial Officer2024-02-014,115$1.95
$8.02kSell
James F. Oliviero IiiCEO President and Director2024-02-0111,900$2.01
$23.92kSell

1 of 1

CKPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CKPT insiders and whales buy or sell their stock.

CKPT Shareholders

What type of owners hold Checkpoint Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC6.80%2,426,000$3.52MInstitution
Fortress Biotech Inc5.87%2,096,278$3.04MInsider
Vanguard Group Inc1.54%548,308$795.05kInstitution
James F. Oliviero Iii0.96%341,780$495.58kInsider
Geode Capital Management LLC0.49%173,844$252.07kInstitution
Blackrock Inc0.47%166,516$241.45kInstitution
Renaissance Technologies LLC0.46%165,731$240.31kInstitution
B Riley Wealth Advisors Inc0.46%163,350$236.86kInstitution
Osaic Holdings Inc0.46%163,283$236.76kInstitution
William Garrett Gray0.41%145,224$210.57kInsider

1 of 3

CKPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CKPT13.69%8.02%Net SellingNet Selling
OCEA13.42%75.32%
ABIO4.98%95.02%
CALC2.26%97.74%Net BuyingNet Buying
MAIA4.02%21.29%Net BuyingNet Buying
View Top Biotech Stocks

Checkpoint Therapeutics Stock Ownership FAQ

Who owns Checkpoint Therapeutics?

Checkpoint Therapeutics (NASDAQ: CKPT) is owned by 13.69% institutional shareholders, 8.02% Checkpoint Therapeutics insiders, and 78.29% retail investors. Fortress Biotech Inc is the largest individual Checkpoint Therapeutics shareholder, owning 2.10M shares representing 5.87% of the company. Fortress Biotech Inc's Checkpoint Therapeutics shares are currently valued at $3.01M.

If you're new to stock investing, here's how to buy Checkpoint Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.